Read more stories about
Montana Biotech >>

MATR Sponsor:

MATR Supporters:

Bozeman, Montana based SensoPath Technologies gets contract to continue cancer research

October 23, 2012View for printing

Local biotechnology company SensoPath Technologies has received a $1.5 million contract from the National Cancer Institute at the National Institutes of Health.

The contract will go toward the company's Phase II research into its treatment for recurring head and neck cancers.

JASON BACAJ, Business Journal Editor

Full Story: ... cf887a.html

No reader comments so far. Be the first to comment by clicking the button below.

Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

E-mail this page to a friend!